Literature DB >> 7583911

Structural and functional properties of human lambda-light-chain variable-region subgroups.

A Solomon1, D T Weiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7583911      PMCID： PMC170166          DOI： 10.1128/cdli.2.4.387-394.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  47 in total

1.  Activation of an excluded immunoglobulin allele in a human B lymphoma cell line.

Authors:  N Berinstein; S Levy; R Levy
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  First genomic sequence of a human Ig variable lambda gene belonging to subgroup I. Functional genes, pseudogenes and vestigial sequences are interspersed in the IGLV locus.

Authors:  D Alexandre; P Chuchana; F Brockly; A Blancher; G Lefranc; M P Lefranc
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

3.  Canonical structures for the hypervariable regions of immunoglobulins.

Authors:  C Chothia; A M Lesk
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

4.  Cloning and sequence analysis of an Ig lambda light chain mRNA expressed in the Burkitt's lymphoma cell line EB4.

Authors:  M L Anderson; L Brown; E McKenzie; J E Kellow; B D Young
Journal:  Nucleic Acids Res       Date:  1985-04-25       Impact factor: 16.971

5.  Complementary DNA for a human subgroup IV immunoglobulin lambda-chain.

Authors:  N Yamasaki; S Komori; T Watanabe
Journal:  Mol Immunol       Date:  1987-09       Impact factor: 4.407

6.  Serologically defined V region subgroups of human lambda light chains.

Authors:  A Solomon; D T Weiss
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

7.  Human lambda light chain locus: organization and DNA sequences of three genomic J regions.

Authors:  J A Udey; B Blomberg
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

8.  Distinctive serologic, chemical, and molecular properties of human lambda IV light chains.

Authors:  M Eulitz; L Y Ch'ang; C Zirkel; M Schell; D T Weiss; A Solomon
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

9.  Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).

Authors:  A Solomon; B Frangione; E C Franklin
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

10.  Mutational hot spots in Ig V region genes of human follicular lymphomas.

Authors:  S Levy; E Mendel; S Kon; Z Avnur; R Levy
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307
View more
  7 in total

1.  In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable region.

Authors:  Kalliopi Skamaki; Stephane Emond; Matthieu Chodorge; John Andrews; D Gareth Rees; Daniel Cannon; Bojana Popovic; Andrew Buchanan; Ralph R Minter; Florian Hollfelder
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-16       Impact factor: 11.205

2.  The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain.

Authors:  Elena S Klimtchuk; Olga Gursky; Rupesh S Patel; Kathryn L Laporte; Lawreen H Connors; Martha Skinner; David C Seldin
Journal:  Biochemistry       Date:  2010-10-20       Impact factor: 3.162

3.  Antigen nature and complexity influence human antibody light chain usage and specificity.

Authors:  Kenneth Smith; Hemangi Shah; Jennifer J Muther; Angie L Duke; Kathleen Haley; Judith A James
Journal:  Vaccine       Date:  2016-04-23       Impact factor: 3.641

4.  Trade-offs in antibody repertoires to complex antigens.

Authors:  Lauren M Childs; Edward B Baskerville; Sarah Cobey
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

Review 5.  Antibody Diversity in Cancer: Translational Implications and Beyond.

Authors:  Raghuram Reddy; Joel Mintz; Roei Golan; Fakiha Firdaus; Roxana Ponce; Derek Van Booven; Aysswarya Manoharan; Isabelle Issa; Bonnie B Blomberg; Himanshu Arora
Journal:  Vaccines (Basel)       Date:  2022-07-22

6.  Inhibition by small-molecule ligands of formation of amyloid fibrils of an immunoglobulin light chain variable domain.

Authors:  Boris Brumshtein; Shannon R Esswein; Lukasz Salwinski; Martin L Phillips; Alan T Ly; Duilio Cascio; Michael R Sawaya; David S Eisenberg
Journal:  Elife       Date:  2015-11-18       Impact factor: 8.140

Review 7.  Antibody-Drug Conjugates-A Tutorial Review.

Authors:  Stephanie Baah; Mark Laws; Khondaker Miraz Rahman
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.